Results 151 to 160 of about 482,963 (230)

Ultrasound elastography in pediatric care: bridging innovation and noninvasive diagnostics. [PDF]

open access: yesItal J Pediatr
Piersanti M   +11 more
europepmc   +1 more source

Tendinopathy: Types, Epidemiology, Molecular Mechanisms, and Future Precision‐Oriented Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
This review presents tendinopathy as a heterogeneous disorder driven by dynamic interactions among mechanical sensing, inflammation, angiogenesis and innervation, and extracellular matrix remodeling. Integrating clinical phenotypes with imaging, biomarkers, and multi‐omics may enable molecular subtyping and mechanism‐guided interventions, advancing ...
Yang Wu   +4 more
wiley   +1 more source

Ocular Ultrasound Elastography for Intraocular Tumors: A Pilot Study. [PDF]

open access: yesCureus
Moreno Solano HG   +4 more
europepmc   +1 more source

A Novel MR Elastography Device for Preclinical Applications From Spheroids to Rodents: Design, Validation, and Performance Evaluation

open access: yesNMR in Biomedicine, Volume 39, Issue 11, November 2026.
MR elastography (MRE) noninvasively assesses tissue biomechanics, but preclinical research suffers from diverse hardware solutions, hindering reproducibility and comparability. This study introduces a versatile preclinical MRE device for imaging rodents, ex vivo samples, and spheroids/organoids.
Gabrielle Mangin   +14 more
wiley   +1 more source

The diagnostic value of conventional ultrasound combined with ultrasonic elastography in mucinous breast carcinoma

open access: yes肿瘤影像学
Objective: To analyze the clinical characteristics and ultrasonic manifestations of breast mucinous carcinoma and explore the diagnostic value of conventional ultrasound combined with ultrasonic elastography in breast mucinous carcinoma.
SONG Jiajia, ZHANG Yidan, KONG Wentao
doaj  

Review Article: Fibrosis Reversal in Metabolic Dysfunction‐Associated Steatohepatitis—The Promise of Emerging Therapeutics

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 9, Page 1184-1196, November 2026.
Metabolic dysfunction‐associated steatohepatitis is the second commonest US indication for liver transplantation but remains largely undiagnosed and untreated. Fibrosis stage is the strongest predictor of major adverse liver outcomes, with decompensation rates and transplant‐free survival diverging sharply between F3 and F4, while cardiovascular ...
Malek Ayoub   +2 more
wiley   +1 more source

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real‐Life Experience From a National Reference Network

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10318-10329, November 2026.
ABSTRACT Aim Lipodystrophy syndromes are rare diseases with metabolic and cardiovascular consequences. This study explores the metabolic and renal effects of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with genetic lipodystrophy. Patients and Methods Patients with familial partial lipodystrophy (n = 57) or congenital generalised ...
Léna Robert   +12 more
wiley   +1 more source

Real-Time Ultrasound Elastography in Multiple Sclerosis Spasticity: Comparison with Clinical and Neurophysiological Measures. [PDF]

open access: yesJ Clin Med
Bakola E   +7 more
europepmc   +1 more source

Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction‐Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open‐Label Trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10163-10172, November 2026.
ABSTRACT Aims Type 2 diabetes drives the progression of metabolic dysfunction‐associated steatohepatitis (MASH). We evaluated whether antidiabetic therapy, specifically adding sodium–glucose cotransporter 2 (SGLT2) inhibitor to a glucagon‐like peptide‐1 receptor agonist (GLP‐1RA), improves liver histology in adults with biopsy‐proven MASH and type 2 ...
Teruki Miyake   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy